Clover Health Investments, Corp.
$5.26▼ 2.41%($-0.13)
TickerSpark Score
60/100
▌ Mixed
65
Valuation
25
Profitability
55
Growth
56
Health
100
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLOV research report →
52-Week Range92% of range
Low
$1.58
Current
$5.26
High
$5.59
Company Overviewwww.cloverhealth.com
About the company
Clover Health Investments, Corp. is a U. S.
- CEO
- Andrew Toy
- IPO
- 2020
- Employees
- 570
- HQ
- Franklin, TN, US
Price Chart
+103.09% · this period
Valuation
- Market Cap
- $2.73B
- P/E
- -47.26
- P/S
- 1.23
- P/B
- 8.09
- EV/EBITDA
- -46.24
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 18.39%
- Op Margin
- -2.57%
- Net Margin
- -2.58%
- ROE
- -17.08%
- ROIC
- -15.76%
Growth & Income
- Revenue
- $1.92B · 40.34%
- Net Income
- $-85,549,000 · -98.91%
- EPS
- $-0.17 · -93.62%
- Op Income
- $-85,529,000
- FCF YoY
- -307.21%
Performance & Tape
- 52W High
- $5.59
- 52W Low
- $1.58
- 50D MA
- $3.86
- 200D MA
- $2.81
- Beta
- 2.48
- Avg Volume
- 7.71M
Get TickerSpark's AI analysis on CLOV
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 1, 26 | Toy Andrew | sell | 313,476 |
| Jun 17, 26 | Reynoso Jamie L. | sell | 2,360 |
| Jun 16, 26 | OLDAKOWSKI JOSEPH FRANK | sell | 12,102 |
| Jun 15, 26 | Soares Karen | sell | 4,681 |
| Jun 15, 26 | Reynoso Jamie L. | sell | 6,350 |
| Jun 11, 26 | Reynoso Jamie L. | sell | 7,289 |
| May 28, 26 | Wai Conrad | sell | 220,426 |
| May 18, 26 | Edwards Carladenise Armbrister | sell | 67,160 |
| May 16, 26 | THORNTON JOSEPH CLAY | other | 16,942 |
| May 13, 26 | Priest Brady Patrick | sell | 98,039 |
Coverage · CLOV
Our CLOV coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on CLOV yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CLOV report →Internal Compare
Similar companies
Peers in the same neighborhood.
PRCT▼10.40%
PROCEPT BioRobotics Corporation
$21.03
TWST▼2.94%
Twist Bioscience Corporation
$99.24
QDEL▲0.39%
QuidelOrtho Corporation
$18.25
NHC▲2.69%
National HealthCare Corporation
$218.44
BGM▼10.87%
BGM Group Ltd.
$0.32
GRDN▼0.31%
Guardian Pharmacy Services, Inc.
$42.00
LFST▼1.40%
LifeStance Health Group, Inc.
$11.27
GPCR▲2.55%
Structure Therapeutics Inc.
$53.45